Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Cited by CrossRef (5)

  1. Jitendra Gupta, Abduladheem Turki Jalil, Zainab Al-hawraa Riyad Muedii, Zafar Aminov, Fahad Alsaikhan, Andrés Alexis Ramírez-Coronel, Pushpamala Ramaiah, Bagher Farhood. The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review. CMC 2024;31:6992
    https://doi.org/10.2174/0109298673248404231006052436
  2. Kai Huang, Chen Yan, Lina Abdelghany, Xu Zhang, Keiichi Jingu, Tao-Sheng Li. Nicaraven attenuates the acquired radioresistance of established tumors in mouse models via PARP inhibition. Mol Cell Biochem 2024
    https://doi.org/10.1007/s11010-024-04958-6
  3. Milad Ashrafizadeh, Wei Zhang, Yu Tian, Gautam Sethi, Xianbin Zhang, Aiming Qiu. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation. Cancer Metastasis Rev 2024;43:229
    https://doi.org/10.1007/s10555-024-10168-9
  4. Feng Lyu, Shi-Yu Shang, Xian-Shu Gao, Ming-Wei Ma, Mu Xie, Xue-Ying Ren, Ming-Zhu Liu, Jia-Yan Chen, Shan-Shi Li, Lei Huang. Uncovering the Secrets of Prostate Cancer’s Radiotherapy Resistance: Advances in Mechanism Research. Biomedicines 2023;11:1628
    https://doi.org/10.3390/biomedicines11061628
  5. Payel Dey, Rima Das, Sandipan Chatterjee, Roni Paul, Utpal Ghosh. Combined effects of carbon ion radiation and PARP inhibitor on non-small cell lung carcinoma cells: Insights into DNA repair pathways and cell death mechanisms. DNA Repair 2024;144:103778
    https://doi.org/10.1016/j.dnarep.2024.103778
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd